Want to join the conversation?
$DOW's sales for 2Q16 decreased by 7% from last year. This decline was primarily driven by lower hydrocarbons and raw material prices and the impact from the Dow Chlorine Products divestiture. Cash flow from operations rose to $2.2Bil from $1.4Bil, on ongoing disciplined actions to manage working capital as well as higher earnings.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?